Mind Medicine Inc (NASDAQ:MNMD)’s traded shares stood at 1.48 million during the last session, with the company’s beta value hitting 1.77. At the close of trading, the stock’s price was $6.70, to imply a decrease of -1.76% or -$0.12 in intraday trading. The MNMD share’s 52-week high remains $12.22, putting it -82.39% down since that peak but still an impressive 30.45% since price per share fell to its 52-week low of $4.66.
Analysts have given a consensus recommendation of Buy for Mind Medicine Inc (MNMD), translating to a mean rating of 1.10. Of 2 analyst(s) looking at the stock, 0 analyst(s) give MNMD a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.28.
Mind Medicine Inc (NASDAQ:MNMD) trade information
After registering a -1.76% downside in the last session, Mind Medicine Inc (MNMD) has traded red over the past five days. The 5-day price performance for the stock is -18.09%, and -9.83% over 30 days. With these gigs, the year-to-date price performance is -3.74%.
The extremes give us $14 and $14 for target low and target high price respectively. As such, MNMD has been trading -108.96% off suggested target high and -108.96% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 2.29% for the past 5-year period. While 2025 is set for a 41.32% return in earnings, projections for the next 5 years are at 14.93% annually.
MNMD Dividends
Mind Medicine Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
We also have iShares Russell 2000 ETF and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Mind Medicine Inc (MNMD) shares. Going by data provided on Nov 30, 2024 , iShares Russell 2000 ETF holds roughly 2.03 shares. This is just over 2.77% of the total shares, with a market valuation of $13.61 million. Data from the same date shows that the other fund manager holds a little less at 1.05, or 1.43% of the shares, all valued at about 7.04 million.
